| Target Price consensus revisions : last 18 months |
|
|
|
| Evolution of the average Target Price on ABBVIE |
|
|
|
Assessed data source
© 2019 S&P Global Market Intelligence
|
|
|
AstraZeneca shares rise on early U.S. approval for leukaemia drug |
| Mean consensus |
OUTPERFORM |
| Number of Analysts |
12 |
| Average target price |
95,18 $ |
| Last Close Price |
86,44 $ |
| Spread / Highest target |
50,4% |
| Spread / Average Target |
10,1% |
| Spread / Lowest Target |
-6,29% |
Consensus revision (last 18 months)
|
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report 
